Literature DB >> 35371558

The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia.

Galya V Klink1, Ksenia R Safina1, Elena Nabieva2, Nikita Shvyrev3, Sofya Garushyants1, Evgeniia Alekseeva2, Andrey B Komissarov4, Daria M Danilenko4, Andrei A Pochtovyi5, Elizaveta V Divisenko5, Lyudmila A Vasilchenko5, Elena V Shidlovskaya5, Nadezhda A Kuznetsova5, Anna S Speranskaya6, Andrei E Samoilov6, Alexey D Neverov6, Anfisa V Popova6, Gennady G Fedonin6, Vasiliy G Akimkin6, Dmitry Lioznov4, Vladimir A Gushchin5, Vladimir Shchur3, Georgii A Bazykin2.   

Abstract

Delta has outcompeted most preexisting variants of SARS-CoV-2, becoming the globally predominant lineage by mid-2021. Its subsequent evolution has led to the emergence of multiple sublineages, most of which are well-mixed between countries. By contrast, here we show that nearly the entire Delta epidemic in Russia has probably descended from a single import event, or from multiple closely timed imports from a single poorly sampled geographic location. Indeed, over 90 per cent of Delta samples in Russia are characterized by the nsp2:K81N + ORF7a:P45L pair of mutations which is rare outside Russia, putting them in the AY.122 sublineage. The AY.122 lineage was frequent in Russia among Delta samples from the start, and has not increased in frequency in other countries where it has been observed, suggesting that its high prevalence in Russia has probably resulted from a random founder effect rather than a transmission advantage. The apartness of the genetic composition of the Delta epidemic in Russia makes Russia somewhat unusual, although not exceptional, among other countries.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Keywords:  AY.122; Delta lineage; ORF7a:P45L; SARS-CoV2 in Russia; cross-border transmission of SARS-CoV2; genomic epidemiology of SARS-CoV2

Year:  2022        PMID: 35371558      PMCID: PMC8966696          DOI: 10.1093/ve/veac017

Source DB:  PubMed          Journal:  Virus Evol        ISSN: 2057-1577


  40 in total

1.  FastTree 2--approximately maximum-likelihood trees for large alignments.

Authors:  Morgan N Price; Paramvir S Dehal; Adam P Arkin
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

2.  Superspreading drives the COVID pandemic - and could help to tame it.

Authors:  Dyani Lewis
Journal:  Nature       Date:  2021-02       Impact factor: 49.962

3.  HyPhy 2.5-A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies.

Authors:  Sergei L Kosakovsky Pond; Art F Y Poon; Ryan Velazquez; Steven Weaver; N Lance Hepler; Ben Murrell; Stephen D Shank; Brittany Rife Magalis; Dave Bouvier; Anton Nekrutenko; Sadie Wisotsky; Stephanie J Spielman; Simon D W Frost; Spencer V Muse
Journal:  Mol Biol Evol       Date:  2020-01-01       Impact factor: 16.240

4.  Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7.

Authors:  Andrew Rambaut; Alexei J Drummond; Dong Xie; Guy Baele; Marc A Suchard
Journal:  Syst Biol       Date:  2018-09-01       Impact factor: 15.683

5.  VSEARCH: a versatile open source tool for metagenomics.

Authors:  Torbjørn Rognes; Tomáš Flouri; Ben Nichols; Christopher Quince; Frédéric Mahé
Journal:  PeerJ       Date:  2016-10-18       Impact factor: 2.984

6.  B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.

Authors:  Prerna Arora; Anzhalika Sidarovich; Nadine Krüger; Amy Kempf; Inga Nehlmeier; Luise Graichen; Anna-Sophie Moldenhauer; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Metodi V Stankov; Georg M N Behrens; Stefan Pöhlmann; Markus Hoffmann
Journal:  Cell Rep       Date:  2021-09-28       Impact factor: 9.423

7.  Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.

Authors:  David N Fisman; Ashleigh R Tuite
Journal:  CMAJ       Date:  2021-10-04       Impact factor: 8.262

8.  A new framework and software to estimate time-varying reproduction numbers during epidemics.

Authors:  Anne Cori; Neil M Ferguson; Christophe Fraser; Simon Cauchemez
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

9.  CoV-Spectrum: Analysis of Globally Shared SARS-CoV-2 Data to Identify and Characterize New Variants.

Authors:  Chaoran Chen; Sarah Nadeau; Michael Yared; Philippe Voinov; Ning Xie; Cornelius Roemer; Tanja Stadler
Journal:  Bioinformatics       Date:  2021-12-25       Impact factor: 6.937

View more
  7 in total

1.  Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance.

Authors:  Andrey S Shkoda; Vladimir A Gushchin; Darya A Ogarkova; Svetlana V Stavitskaya; Olga E Orlova; Nadezhda A Kuznetsova; Elena N Keruntu; Andrei A Pochtovyi; Alexander V Pukhov; Denis A Kleymenov; Vasyli G Krzhanovsky; Daria V Vasina; Nataliya V Shkuratova; Elena V Shidlovskaya; Alexey L Gorbunov; Daria D Kustova; Evgeniya A Mazurina; Sofya R Kozlova; Alexandra V Soboleva; Igor V Grigoriev; Lyudmila L Pankratyeva; Alina S Odintsova; Elizaveta D Belyaeva; Arina A Bessonova; Lyudmila A Vasilchenko; Igor P Lupu; Ruslan R Adgamov; Artem P Tkachuk; Elizaveta A Tokarskaya; Denis Y Logunov; Alexander L Gintsburg
Journal:  Vaccines (Basel)       Date:  2022-06-13

2.  Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction.

Authors:  Priyanka Mehta; Varsha Ravi; Priti Devi; Ranjeet Maurya; Shaista Parveen; Pallavi Mishra; Aanchal Yadav; Aparna Swaminathan; Sheeba Saifi; Kriti Khare; Partha Chattopadhyay; Monika Yadav; Nar Singh Chauhan; Bansidhar Tarai; Sandeep Budhiraja; Uzma Shamim; Rajesh Pandey
Journal:  Microbiol Res       Date:  2022-06-25       Impact factor: 5.070

3.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.

Authors:  Ivan A Molodtsov; Evgenii Kegeles; Alexander N Mitin; Olga Mityaeva; Oksana E Musatova; Anna E Panova; Mikhail V Pashenkov; Iuliia O Peshkova; Almaqdad Alsalloum; Walaa Asaad; Anna S Budikhina; Alexander S Deryabin; Inna V Dolzhikova; Ioanna N Filimonova; Alexandra N Gracheva; Oxana I Ivanova; Anastasia Kizilova; Viktoria V Komogorova; Anastasia Komova; Natalia I Kompantseva; Ekaterina Kucheryavykh; Denis А Lagutkin; Yakov A Lomakin; Alexandra V Maleeva; Elena V Maryukhnich; Afraa Mohammad; Vladimir V Murugin; Nina E Murugina; Anna Navoikova; Margarita F Nikonova; Leyla A Ovchinnikova; Yana Panarina; Natalia V Pinegina; Daria M Potashnikova; Elizaveta V Romanova; Aleena A Saidova; Nawar Sakr; Anastasia G Samoilova; Yana Serdyuk; Naina T Shakirova; Nina I Sharova; Saveliy A Sheetikov; Anastasia F Shemetova; Liudmila V Shevkova; Alexander V Shpektor; Anna Trufanova; Anna V Tvorogova; Valeria M Ukrainskaya; Anatoliy S Vinokurov; Daria A Vorobyeva; Ksenia V Zornikova; Grigory A Efimov; Musa R Khaitov; Ilya A Kofiadi; Alexey A Komissarov; Denis Y Logunov; Nelli B Naigovzina; Yury P Rubtsov; Irina A Vasilyeva; Pavel Volchkov; Elena Vasilieva
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

4.  COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.

Authors:  Anton Barchuk; Dmitriy Skougarevskiy; Alexei Kouprianov; Daniil Shirokov; Olga Dudkina; Rustam Tursun-Zade; Mariia Sergeeva; Varvara Tychkova; Andrey Komissarov; Alena Zheltukhina; Dmitry Lioznov; Artur Isaev; Ekaterina Pomerantseva; Svetlana Zhikrivetskaya; Yana Sofronova; Konstantin Blagodatskikh; Kirill Titaev; Lubov Barabanova; Daria Danilenko
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

5.  Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.

Authors:  Alisher Abdullaev; Abrorjon Abdurakhimov; Zebinisa Mirakbarova; Shakhnoza Ibragimova; Vladimir Tsoy; Sharofiddin Nuriddinov; Dilbar Dalimova; Shahlo Turdikulova; Ibrokhim Abdurakhmonov
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

6.  Variational Phylodynamic Inference Using Pandemic-scale Data.

Authors:  Caleb Ki; Jonathan Terhorst
Journal:  Mol Biol Evol       Date:  2022-08-03       Impact factor: 8.800

7.  Effective Approaches to Study the Genetic Variability of SARS-CoV-2.

Authors:  Ivan Kotov; Valeriia Saenko; Nadezhda Borisova; Anton Kolesnikov; Larisa Kondrasheva; Elena Tivanova; Kamil Khafizov; Vasily Akimkin
Journal:  Viruses       Date:  2022-08-24       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.